Author:
Li Wen,Wang Min,Wang Lingyun,Ji Shusheng,Zhang Junyong,Zhang Chunqing
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Reference49 articles.
1. Trevisani, F., Cantarini, M. C., Wands, J. R., & Bernardi, M. (2008). Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis, 29(7), 1299–1305.
2. Hsu, C., Cheng, J. C., & Cheng, A. L. (2004). Recent advances in non-surgical treatment for advanced hepatocellular carcinoma. Journal of the Formosan Medical Association, 103(7), 483–495.
3. Llovet, J. M., Burroughs, A., & Bruix, J. (2003). Hepatocellular carcinoma. Lancet, 362(9399), 1907–1917.
4. El-Serag, H. B., Siegel, A. B., Davila, J. A., Shaib, Y. H., Cayton-Woody, M., McBride, R., et al. (2006). Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. Journal of Hepatology, 44(1), 158–166.
5. Yeo, W., Mok, T. S., Zee, B., Leung, T. W., Lai, P. B., Lau, W. Y., et al. (2005). A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. Journal of the National Cancer Institute, 97(20), 1532–1538.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献